Telomeres are biological protective structures that shorten with each cell division and accelerate ageing. Vitamin D3 supplementation (2000 IU/day) significantly slowed telomere shortening in one large RCT, but the effect is modest. Longer telomeres are not by definition healthier, as the relationship with cancer risk is complex and cancer-type dependent.
Telomeres are protective caps at the ends of your chromosomes, similar to the plastic tips on a shoelace that prevent it from fraying. Every time a cell divides, these caps become slightly shorter. When telomeres become too short, the cell can no longer divide, tissue ages more rapidly, and the risk of age-related diseases increases. Greater telomere shortening predicts higher mortality and more age-related diseases, both in people with hereditary telomere disorders and in the general population (PMID 26785477, 30650660).
Aged cells that have stopped dividing due to telomere shortening do not always disappear on their own. They remain active and secrete substances that promote inflammation, which in turn contributes to age-related diseases. In animal experiments, lifespan and health improved when such senescent cells were removed, but whether this is safe and effective in humans has not yet been established (PMID 29114066).
The most concrete evidence for a lifestyle measure comes from the large VITAL study, a randomised controlled trial involving more than 1000 participants. Daily intake of 2000 IU of vitamin D3 significantly slowed telomere shortening over four years: telomeres were on average 0.14 kilobase pairs less shortened than in the placebo group. That sounds small, but it is a measurable and statistically reliable difference. Supplementation with 1 gram per day of omega-3 fatty acids had no significant effect on telomere length in the same study (PMID 40409468).
An important nuance: longer telomeres are not always better. Genetically determined variations in telomere maintenance can increase the risk of certain types of cancer while decreasing it for others. The relationship is cancer-type-specific and complex. In addition, some cancer cells use a special evasion mechanism to keep their telomeres long, allowing them to keep dividing. This shows that simply aiming for 'the longest possible telomeres' is not a straightforward health goal (PMID 26785477, 41303422, 38593805).
Telomere shortening in white blood cells is also associated with immune problems, such as the rare syndrome dyskeratosis congenita, in which the immune system is severely compromised (PMID 39317127). All in all, telomeres are an interesting but complex biological clock. There is modest evidence that vitamin D3 supplementation can slightly slow telomere shortening, but large-scale interventions aimed at lengthening telomeres have not yet been proven safe or effective for healthy people.
Based on observational studies, genetic association studies, and one large RCT (VITAL). The causal role of telomere shortening in ageing is plausible but not fully proven in humans. Effect sizes for the vitamin D3 finding are modest.